FDA Approves LURASIDONE HYDROCHLORIDE — Aurobindo Pharma Limited

# FDA Approves Generic Lurasidone Hydrochloride; Aurobindo Pharma Enters Antipsychotic Market Aurobindo Pharma Limited has received FDA approval for its generic formulation of lurasidone hydrochloride, an atypical antipsychotic used to treat schizophrenia and bipolar depression, potentially capturing market share from branded competitor Latuda. The approval is expected to increase price competition and improve patient access to this psychiatric medication in the U.S. market.